Early experience of maintenance durvalumab post chemoradiation (CRT) in stage III non-small cell lung cancer (NSCLC) across West Yorkshire network: from Expanded Access Programme (EAP) to routine clinical use. (January 2020) - Jain, P.; Murray, P.; Clarke, K.; Franks, K.; Teo, M.; Saha, A.; Chan, S.; Conn, A.; Brown, N.; Rathbone, E.